• DORSOMORPHIN CHEMBL478629

    Alternate Names:

    Dorsomorphin
    BML-275|||COMPOUND C|||6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE
    6-?[4-?[2-?(1-?PIPERIDINYL)ETHOXY]PHENYL]-?3-?(4-?PYRIDINYL)-?PYRAZOLO[1,?5-?A]PYRIMIDINE
    6-[4-[2-(1-PIPERIDINYL)ETHOXY]PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE
    4-(6-{4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL}PYRAZOLO[1,5-ALPHA]PYRIMIDIN-3-YL)PYRIDINE
    C516138000
    I14-15264
    BRD-K54233340-300-01-0
    A841757
    KB-145998
    HE101077
    HE066743
    AK-88052
    AJ-64447
    NCGC00165869-03
    NCGC00165869-02
    NCGC00165869-01
    TRA0096953
    RTX-010382
    MCULE-1245787291
    DB08597
    CS-2487
    CCG-206817
    AKOS005255631
    ZINC13829435
    IN1530
    HY-13418A
    DNC014891
    BDBM50262685
    ANW-67560
    HMS3229A20
    MOLPORT-006-709-961
    BML 275
    AOB3605
    CTK5J7339
    QCR-60
    GTPL4907
    SCHEMBL463155
    AMPK INHIBITOR
    6-[4-(2-PIPERIDIN-1-YL-ETHOXY)-PHENYL)]-3-PYRIDIN-4-YL-PYRRAZOLO[1,5-A]-PYRIMIDINE
    INSOLUTION™ AMPK INHIBITOR, COMPOUND C
    IN1529
    CHEBI:78510
    BML275
    4-(6-{4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL}PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)PYRIDINE
    BML-275
    AMPK INHIBITOR, COMPOUND C
    866405-64-3
    COMPOUND C
    11524144
    P5499_SIGMA
    6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
    178101606
    4907

    Drug Info:

    Drug Categories N/A
    Drug Groups experimental
    Drug Type small molecule
    (0 More Sources)
  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assayed using AMPK heterotrimeric complex containing α2, β1, γ1 subunits
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

  • Interaction Types:
    n/a

    Interaction Info: